Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-1.40%
202413.16%
2023-9.83%
202254.24%
2021-86.07%
202031.97%
20196.98%
2018-7.44%
201734.03%
201610.40%